Paradigm Biopharmaceuticals | PAR - Net Income

Stock Price
0.26
Daily Change
0.01 2.00%
Monthly
-12.07%
Yearly
-38.55%
Q1 Forecast
0.25

Paradigm Biopharmaceuticals reported AUD-6.42M in Net Income for its fiscal semester ending in June of 2025.





Net Income Change Date
Avita Medical AUD -11.62M 1.7M Dec/2025
Medical Developments International AUD -226K 121K Dec/2025
Neuren Pharmaceuticals AUD 15.4M 7.88M Dec/2025
Pacific Edge NZD -19.12M 3.68M Dec/2025
PYC Therapeutics AUD -22.83M 10.46M Dec/2025
Telix Pharmaceuticals AUD -4.83M 2.54M Dec/2025